Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
PT Novell Pharmaceutical Laboratories oversees production operations to ensure quality and regulatory compliance. You will monitor raw materials, equipment availability and workforce allocation while enforcing safety in the production area.
The role requires a Pharmacy qualification or a Bachelor’s in Food Technology, at least two years in production leadership within pharma or food, and solid knowledge of GMP, HACCP and ISO 22000 with strong leadership and communication abilities.
Responsible for production operations, ensuring all production processes meet quality standards and compliance with applicable regulations. Monitor raw material usage, machine availability and labour allocation. Implement and monitor occupational safety and health in the production area. Prepare reports related to production target achievement, operational constraints and continuous improvement proposals.
Responsible for production operations
Ensure all production processes meet quality standards and compliance with applicable regulations
Monitor raw material usage, machine availability and labour allocation
Implement and monitor occupational safety and health in the production area
Prepare reports on production target achievement, operational constraints and continuous improvement proposals
Professional qualification in Pharmacy or Bachelor's degree in Food Technology
Minimum 2 years of work experience as Production Supervisor or Production Leader in production process in pharmaceutical or food industry
Understanding of CPOB, CPOTB, CPPOB / GMP, HACCP and ISO 22000 principles
Leadership spirit and good communication skills
Novell Pharmaceutical Laboratories was established in 1998 as a consequence of increasing globalisation and trend toward efficiency in the pharmaceutical industry.
After a worldwide merger between pharmaceutical giant Glaxo International and Burroughs Wellcome in 1996, a group of foreign and local investors acquired ex-PT.Burroughs Wellcome manufacturing plant in Indonesia and established a new company, which is called Novell Pharmaceutical Laboratories which has a status as a foreign investment company and registered with Indonesian Coordinating Investment Board (BKPM).
The word Novell comes from an English word Novel that translates as something new, fresh and also brings the meaning of innovation.
In June 2011, Novell obtained its approval from Australian Therapeutic Goods Administration (TGA), in 2009 from GCC, in 2009 from South Africa MCC, in 2009 from UAE, in 2010 from Kenya and in 2011 from Turkey as a proof of its constant improvement in its quality process to ensure quality products for all its customers.
In 2013, Novell Pharma becomes the first Indonesian local pharma company to obtain GMP approval from European Union authority (Germany – Lageso) for its injectable plant. Novell also becomes the only company to have GMP license from Europe, Australia, South Africa PICS and GCC Gulf Countries.
As part of its international expansion, Novell has its own office and marketing team in the Philippines, Thailand and Vietnam, with more than 30 employees outside Indonesia.
Novell Pharmaceutical Laboratories was established in 1998 as a consequence of increasing globalisation and trend toward efficiency in the pharmaceutical industry.
After a worldwide merger between pharmaceutical giant Glaxo International and Burroughs Wellcome in 1996, a group of foreign and local investors acquired ex-PT.Burroughs Wellcome manufacturing plant in Indonesia and established a new company, which is called Novell Pharmaceutical Laboratories which has a status as a foreign investment company and registered with Indonesian Coordinating Investment Board (BKPM).
The word Novell comes from an English word Novel that translates as something new, fresh and also brings the meaning of innovation.
In June 2011, Novell obtained its approval from Australian Therapeutic Goods Administration (TGA), in 2009 from GCC, in 2009 from South Africa MCC, in 2009 from UAE, in 2010 from Kenya and in 2011 from Turkey as a proof of its constant improvement in its quality process to ensure quality products for all its customers.
In 2013, Novell Pharma becomes the first Indonesian local pharma company to obtain GMP approval from European Union authority (Germany – Lageso) for its injectable plant. Novell also becomes the only company to have GMP license from Europe, Australia, South Africa PICS and GCC Gulf Countries.
As part of its international expansion, Novell has its own office and marketing team in the Philippines, Thailand and Vietnam, with more than 30 employees outside Indonesia.